Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study

Diabetologia

Volumn 40, Issue 6, 1997, Pages 698-705

  Greaves, M ^a   Malia, R G ^b   Goodfellow, K ^b   Mattock, M ^c   Stevens, L K ^d   Stephenson, J M ^d   Fuller, J H ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Albuminuria; Fibrinogen; Insulin dependent diabetes mellitus; Vascular disease; Von Willebrand factor

Indexed keywords

FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0030743530     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050736     Document Type: Article

References (56)

1. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologie Study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than thirty years. Arch Ophthalmol 102: 527-532
2. Orchard TJ, Dorman JS, Maser RE et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124
3. The EURODIAB IDDM Complications Study Group (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37: 278-285
4. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501
5. Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood glucose control on late complications of type 1 diabetes. Lancet 341: 1306-1309
6. Stephenson JM, Fuller JH, Viberti G-C, Sjolie A-K, Navalesi R (1995) The EURODIAB IDDM Complications Study Group. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 38: 599-603
7. Greaves M, Preston FE (1984) Haemostatic abnormalities in diabetics. In: Jarrett RJ (ed) Diabetes and heart disease. Elsevier, Amsterdam, 2: 47-84
8. Greaves M, Pickering C, Knight G et al. (1987) Changes in the factor VIII complex in diabetic ketoacidosis; evidence of endothelial cell damage. Diabetologia 30: 160-165
9. van de Loo J (1995) Circulating factors of the haemostatic systems as indicators of increased or reduced coronary risk. Br J Haematol 91: 777-782
10. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1: 461-463
11. Stehouwer CDA, Stroes ESG, Hackeng WHL, Mulder PGH, Den Ottolander GJH (1991) von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes 40: 971-976
12. Stehouwer CDA, Fischer HRA, van Kuijk AWR, Polak BCP, Donker AJM (1995) Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44: 561-564
13. 1a c. Ann Intern Med 88: 311-316
14. Petty RG, Pottinger BE, Greenwood RM, Pearson JD, Mahler RF (1991) Diabetes is associated with a high incidence of endothelial-binding antibodies which do not correlate with retinopathy, von Willebrand factor, angiotensin-converting enzyme or C-reactive protein. Diabetes Res 17: 115-123
15. Stehouwer CDA, Zellenrath P, Polak BCP et al. (1992) von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia 35: 555-559
16. Meade TW, Mellows S, Brozovic M et al. (1986) Haemostatic function and ischaemic heart disease: principle results of the Northwick Park Heart Study. Lancet 2: 533-537
17. Kannel WB, DÁgostino RB, Belanger AJ (1987) Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 113: 1006-1010
18. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K et al. (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. New Engl J Med 311: 501-505
19. Jarrett RJ, Viberti G-C, Argyropoulos A et al. (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1: 17-19
20. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360
21. Mattock MB, Keen H, Viberti G-C et al. (1988) Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 82-87
22. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC (1989) Plasma lipid and coagulation factor concentrations in insulin-dependent diabetics with microalbuminuria. BMJ. 298: 487-190
23. Lee AJ, Lowe GDO, Woodward M, Tunstall-Pedoe H (1993) Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease and family history: the Scottish Heart Health Study. Br Heart J 69: 338-342
24. Lee AJ, Smith WCS, Lowe GDO et al. (1990) Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol 43: 913-919
25. Folsom AR, Conlan MG, Davis CE, Wu KK (1992) Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol 2: 481-494
26. Eliasson M, Evrin PE, Lundblad DE (1994) Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study. J Clin Epidemiol 47: 513-524
27. Barasch E, Benderly M, Graff E et al. (1995) Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study. J Clin Epidemiol 48: 757-765
28. Ford I, Malik RA, Newrick PG, Preston FE, Ward JD, Greaves M (1992) Relationships between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 68: 628-633
29. Koivisto VA, Stevens LK, Mattock M et al. (1996) Cardiovascular disease and its risk factors in insulin-dependent diabetes in Europe. Diabetes Care 19: 689-697
30. Aldington SJ, Kohner EM, Meuer S, Sjolie A-K, The EURODIAB IDDM Complications Study Group (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38: 437-444
31. Lowe GDO, Drummond MM, Third JLHC et al. (1980) Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia. Thromb Haemost 42: 1503-1507
32. Pilgeram LO, Pickart LR (1968) Control of fibrinogen biosynthesis: the role of free fatty acid. J Atheroscler Res 8: 155-156
33. Ford I, Dent MT, Greaves M, Preston FE, Wilson RM, Ward JD (1991) Correlation of haemostatic and rheological factors with apoproteins in early type 1 diabetes. Thromb Haemost 65: 56
34. Borch-Johnsen K, Kragh Andersen P, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590-596
35. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type 1 diabetes. Am J Med 78: 785-794
36. Feldt-Rasmussen B(1986) Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282-286
37. Elliot TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM (1993) Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 85: 687-693
38. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G (1994) PAI-1 and factor VII activity are higher in insulin-dependent diabetes mellitus patients with microalbuminuria. Diabetes 43: 426-429
39. Collier A, Leach JP, McLellan A, Jardine A, Morton JJ, Small M (1992) Plasma endothelinlike immunoreactivity levels in insulin-dependent diabetes mellitus patients with microalbuminuria. Diabetes Care 15: 1038-1040
40. Fuller JH, Keen H, Jarrett RJ et al. (1979) Haemostatic variables associated with diabetes and its complications. BMJ 2: 964-966
41. Jay RH, Jones SL, Hill CE et al. (1991) Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med 8: 662-667
42. Chooi CC, Gallus AS (1989) Acute phase reaction, fibrinogen level and thrombus size. Thromb Res. 53: 493-501
43. Myrup B, Hansen PM, Jensen T et al. (1995) Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345: 421-422
44. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ (1985) The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res 58: 527-534
45. Donadio JV, Ilstrup DM, Holley KE, Romero JC (1988) Platelet inhibitor treatment of diabetic nephropathy: a 10-year prospective study. Mayo Clin Proc 63: 3-15
46. Solerte SB, Fioravanti M (1987) Hemodynamic alterations in longterm insulin-dependent patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes. Clin Nephrol 28: 138-143
47. Crowley P, Metzger J, Assaf A, Carleton RC, Merrill E, Valeri CR (1994) Low density lipoprotein cholesterol and whole blood viscosity. Ann Clin Lab Sci 24: 533-541
48. Timperley WR, Ward JD, Preston FE, Duckworth T (1976) Clinical and histological studies in diabetic neuropathy: a reassessment of vascular factors in relation to intravascular coagulation. Diabetologia 12: 237-243
49. MacRury SM, Lockhart JC, Small M, Weir AI, MacCuish AC, Lowe GDO (1991) Do rheological variables play a role in diabetic peripheral neuropathy? Diabet Med 8: 232-236
50. Ewing DJ, Martyn CM, Young RJ, Clarke BF (1985) The value of cardiovascular autonomie function test: 10 years experience in diabetes. Diabetes Care 8: 491-498
51. Plater ME, Ford I, Dent MT, Preston FE, Ward JD (1996) Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function. Diabetologia 39: 336-343
52. Woolf AD, Wakerley G, Wallington TB, Scott DGI, Dieppe PA (1987) Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 46: 441-447
53. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC (1996) C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312: 1061-1065
54. Thomas AE, Green FR, Kelleher CH et al. (1991) Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 65: 487-490
55. Krolewski AS, Canessa M, Warram JH et al. (1988) Predisposition to hypertension and susceptibility to renal disease in IDDM. New Engl J Med 318: 140-145
56. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility for diabetic nephropathy. New Engl J Med 320: 1161-1165